Related Experiment Video
Updated: Sep 12, 2025

07:27
Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
Published on: February 7, 2025
615
Robotic Oesophageal Spindle Cell Lipoma Excision
Rajesh Shinde1, Monika Pohekar1, Dns Saikumar1
1Department of Surgical Oncology, Apollo Hospitals, Navi Mumbai, India
Multimedia Manual of Cardiothoracic Surgery : MMCTS
|August 6, 2025
Summary
This case report details a rare spindle cell lipoma (SCL) of the esophagus, a benign tumor. Complete surgical excision is the recommended treatment for this esophageal lipoma.
Area of Science:
- Gastroenterology
- Surgical Pathology
- Oncology
Background:
- Esophageal lipomas are rare benign tumors, comprising less than 1% of all gastrointestinal lipomas.
- Spindle cell lipoma (SCL) is an exceptionally rare variant of esophageal lipoma.
- Accurate diagnosis is crucial to differentiate from malignant esophageal neoplasms.
Purpose of the Study:
- To report a rare case of spindle cell lipoma (SCL) of the esophagus.
- To highlight the diagnostic challenges and management of this rare esophageal tumor.
- To emphasize the importance of histopathological and immunohistochemical analysis.
Main Methods:
- A case study of a 52-year-old female patient presenting with dysphagia.
- Diagnostic procedures included esophago-gastroscopy and computerized tomography (CT) scan of the chest.
- Surgical intervention involved robotic trans-thoracic excision.
- Histopathological and immunohistochemical examinations were performed.
Main Results:
- A large submucosal mass was identified in the esophagus.
- Initial biopsy suggested squamous hyperplasia; final histopathology confirmed SCL.
- Immunohistochemistry showed CD 34 positivity and negative results for desmin and MDM2.
- The patient underwent successful complete excision of the esophageal lesion.
Conclusions:
- Spindle cell lipoma (SCL) of the esophagus is a rare entity requiring precise diagnosis.
- Complete surgical excision is the standard treatment for esophageal SCL.
- Differentiating SCL from malignant esophageal tumors is critical for appropriate patient management.

